(4-Bromo-6-methylpyridin-2-yl)methanamine, 95.0%, 250mg

(E)-3,3-Dimethyl-1-nitrobut-1-ene, 98%, 1g

ethyl 3-nitro-1H-pyrazole-4-carboxylate, 100mg

6-Bromo-7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridine, 98%, 250mg

Na-Acetyl-L-ornithine, 98.0%, 5g

tert-Butyl 7-bromo-3,4-dihydroisoquinoline-2(1H)-carboxylate, 95.0%, 1g

3(2H)-PYRIDAZINONE, 4,5-DICHLORO-2-(TETRAHYDRO-2H-PYRAN-2-YL)-, 95.0%, 250mg

Diphemanil Methylsulfate>98.0%(HPLC)(N)250mg

Ethyl (1S,2R)-1-{[(tert-butoxy)carbonyl]amino}-2-ethenylcyclopropane-1-carboxylate, 97.0%, 100mg

3-(Aminomethyl)-N-methylbenzamide hydrochloride, 95.0%, 1g

Preparation folder with one-part hinged lid, Number of spaces required, 2 10 pcs

Triethylene Glycol Mono(2-propynyl) Ether>96.0%(GC)1g

Chloro[1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene]silver, 97%, 250mg